Dengue: a continuing global threat
Open accessThe DOI matches its Crossref record; 129 of the 130 references it cites were found in a registry or an index.
Abstract
Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ∼50 million dengue infections and ∼500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Until recent advances in vaccine development [16–17], and the approval and potential availability of the first product in 2016 [18], dengue has been unique among the major vector-borne diseases, in that prevention from infection could only be attempted by reducing or eliminating bites by infected vector mosquitoes [19, 20].”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although a vaccine could be available as early as 2016, vector control remains the primary approach used to prevent dengue, the most common and widespread arbovirus of humans worldwide.”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dengue and Dengue Hemorrhagic Fever
Gubler, D. J. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.480 · Cited by 4,310
Self-citationLanciotti, R. S., Calisher, C. H., Gubler, D. J., Chang, G. J., & Vorndam, A. V. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.3.545-551.1992 · Cited by 1,818 · cited 1×
“The most E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s commonly used NAATs are based on a single RT-PCR assay 95,96 , a nested RT-PCR assay 96 or a one-step multiplex RT-PCR assay 97 .”
MethodSelf-citationDengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Endy, T. P., Raengsakulrach, B., Rothman, A. L., Ennis, F. A., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315215 · Cited by 1,632 · cited 1×
“One advantage of this assay is the ability to determine viral titre early in dengue illness, which is believed to be an important predictor of disease severity 102 .”
BackgroundGuzmán, M. G., & Kouri, G. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00171-2 · Cited by 1,163
Spectrum of Disease and Relation to Place of Exposure among Ill Returned Travelers
Freedman, D. O., Weld, L. H., Kozarsky, P. E., Fisk, T., Robins, R., von Sonnenburg, F., Keystone, J. S., Pandey, P., & Cetron, M. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051331 · Cited by 1,081
Dengue and dengue haemorrhagic fever
Rigau-Pérez, J. G., Clark, G. G., Gubler, D. J., Reiter, P., Sanders, E. J., & Vance Vorndam, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)12483-7 · Cited by 1,051
Self-citationCross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C., Edwards, C., Duangchinda, T., Supasa, S., et al. (2010) · Science · doi:10.1126/science.1185181 · Cited by 943 · cited 1×
“The available data suggest that neutralizing antibodies are the major contributors to protective immunity 124,125 , however the role of the cellular immune response requires further study 123 .”
BackgroundCalisher, C. H., Karabatsos, N., Dalrymple, J. M., Shope, R. E., Porterfield, J. S., Westaway, E. G., & Brandt, W. E. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-1-37 · Cited by 893 · cited 1×
“These tests are mainly for research and vaccine studies 90–94 .”
BackgroundOriginal antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
Mongkolsapaya, J., Dejnirattisai, W., Xu, X.-N., Vasanawathana, S., Tangthawornchaikul, N., Chairunsri, A., Sawasdivorn, S., Duangchinda, T., Dong, T., Rowland-Jones, S., et al. (2003) · Nature Medicine · doi:10.1038/nm887 · Cited by 821 · cited 1×
“…CD4 + and CD8 + cells that have a diminished capacity to kill but nonetheless release inflammatory cytokines that contribute to disease severity 51 ; that severe disease is caused by DENVs of increased virulence 52 ; and the suggestion that cross-reactivity between NS1 and human platelets and…”
BackgroundDengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
Halstead, S., & O'Rourke, E. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.146.1.201 · Cited by 804 · cited 5×
“Both in vitro and in vivo , macrophages and monocytes participate in antibody-dependent enhancement (ADE) 18–20 .”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 3
- Vorndam, V. & Kuno, G. In Dengue and Dengue Hemorrhagic Fever (eds Gubler, D. J. & Kuno, G.) 313–333 (CAB International, New York, USA, 1997).
- Gubler, D. J. Serologic diagnosis of dengue/dengue haemorrhagic fever. Dengue Bull. 20, 20–23 (1996).
- Singh, K. R. P. & Paul, S. D. Multiplication of arboviruses in cell lines from Aedes albopictus and Aedes aegypti. Curr. Sci. 37, 65–67 (1968).
Cited by
Items 101–200 of 1,001
Diagnosis of Dengue Infection Using Conventional and Biosensor Based Techniques
Parkash, O., & Shueb, R. H. (2015) · Viruses · doi:10.3390/v7102877 · Cited by 126
“This method shows a sensitivity and specificity of 90% and 98%, respectively, in samples collected after seroconversion [44,45].”
An updated review of avian-origin Tembusu virus: a newly emerging avian Flavivirus
Zhang, W., Chen, S., Mahalingam, S., Wang, M., & Cheng, A. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000908 · Cited by 126
Essential oils with insecticidal activity against larvae of Aedes aegypti (Diptera: Culicidae)
Vera, S. S., Zambrano, D. F., Méndez‐Sánchez, S. C., Rodríguez-Sanabria, F., Stashenko, E. E., & Duque, J. E. (2014) · Parasitology Research · doi:10.1007/s00436-014-3917-6 · Cited by 132
“Dengue is the most important disease transmitted by arthropods in the world; more than 2.5 billion people are at risk of contracting the virus by sharing an area of spatial distribution with the vector Aedes (Stegomyia) aegypti (L., 1762) (Guzman et al. 2010).”
BackgroundInfluentialPhylogeography and Population Dynamics of Dengue Viruses in the Americas
Allicock, O. M., Lemey, P., Tatem, A. J., Pybus, O. G., Bennett, S. N., Mueller, B. A., Suchard, M. A., Foster, J. E., Rambaut, A., & Carrington, C. V. F. (2012) · Molecular Biology and Evolution · doi:10.1093/molbev/msr320 · Cited by 129
“5 billion people at risk of infection (Guzman et al. 2010).”
BackgroundInfluentialZhu, X., He, Z., Yuan, J. X., Wen, W., Huang, X., Hu, Y., Lin, C., Pan, J., Li, R., Deng, H., et al. (2014) · Cellular Microbiology · doi:10.1111/cmi.12339 · Cited by 134
“5 billion people at risk of infection globally (Guzman et al., 2010; Simmons et al., 2012).”
BackgroundInfluentialJing, Q., & Wang, M. (2019) · Global Health Journal · doi:10.1016/j.glohj.2019.06.002 · Cited by 130
Oxidative stress influences positive strand RNA virus genome synthesis and capping
Gullberg, R. C., Jordan Steel, J., Moon, S. L., Soltani, E., & Geiss, B. J. (2015) · Virology · doi:10.1016/j.virol.2014.10.037 · Cited by 124
Dengue-1 Virus Clade Replacement in Thailand Associated with Enhanced Mosquito Transmission
Lambrechts, L., Fansiri, T., Pongsiri, A., Thaisomboonsuk, B., Klungthong, C., Richardson, J. H., Ponlawat, A., Jarman, R. G., & Scott, T. W. (2011) · Journal of Virology · doi:10.1128/jvi.06458-11 · Cited by 125
“An estimated 50 million people experience dengue illness each year, approximately 500,000 of which are associated with severe, life-threatening disease (18).”
BackgroundEconomic Cost of Dengue in Puerto Rico
Halasa, Y. A., Shepard, D. S., & Zeng, W. (2012) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.11-0784 · Cited by 122
“”(20,21) Other factors relate to the person’s genetic risk, the strain and serotype of the infecting virus, the degree of viremia, and immune pathology.(5,9,22,23)”
BackgroundChen, H., Chuang, Y., Lin, Y.-S., Liu, H., Liu, C., Perng, G., & Yeh, T. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004828 · Cited by 139
“5 billion people, over 40% of the world’s population, are now at risk of dengue infection [1, 2].”
BackgroundApproaches to Refining Estimates of Global Burden and Economics of Dengue
Shepard, D. S., Undurraga, E. A., Betancourt-Cravioto, M., Guzmán, M. G., Halstead, S. B., Harris, E., Mudin, R. N., Murray, K. O., TAPIA-CONYER, R. C., & Gubler, D. J. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003306 · Cited by 121
“Other factors, such as travel and trade, may also affect dengue transmission [3,5,6,114].”
BackgroundSelf-citationTeurlai, M., Menkès, C., Cavarero, V., Dégallier, N., Descloux, É., Grangeon, J.-P., Guillaumot, L., Libourel, T., Lúcio, P. S., Mathieu-Daudé, F., et al. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004211 · Cited by 125
Priyamvada, L., Cho, A., Onlamoon, N., Zheng, N., Huang, M., Kovalenkov, Y. O., Chokephaibulkit, K., Angkasekwinai, N., Pattanapanyasat, K., Ahmed, R., et al. (2016) · Journal of Virology · doi:10.1128/jvi.03203-15 · Cited by 121
“Given that all the patients were previously exposed to DENV and that the four DENV serotypes share high genomic sequence homology (5), we were not surprised by the large number of fully cross-reactive MAbs in our panel.”
BackgroundDengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS
He, Z., Zhu, X., Wen, W., Yuan, J. X., Hu, Y., Chen, J., An, S., Dong, X., Lin, C., Yu, J., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00221-16 · Cited by 131
“DENV is one of the most important mosquito-borne viruses affecting humans, causing dengue fever or more severe dengue symptoms such as DHF and DSS.”
BackgroundIncreasing airline travel may facilitate co-circulation of multiple dengue virus serotypes in Asia
Tian, H., Sun, Z., Faria, N. R., Yang, J., Cazelles, B., Huang, S., Xu, B., Yang, Q., Pybus, O. G., & Xu, B. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005694 · Cited by 129
“The geographical areas in which transmission of multiple dengue serotypes occurs has grown in recent years and the pattern of co-circulation is conspicuously different from that which prevailed decades ago [14, 15] .”
BackgroundOpportunistic intruders: how viruses orchestrate ER functions to infect cells
Ravindran, M. S., Bagchi, P., Cunningham, C. N., & Tsai, B. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.60 · Cited by 128
Dengue and Zika Viruses: Epidemiological History, Potential Therapies, and Promising Vaccines
Silva, N. M., Santos, N. C., & Martins, I. C. (2020) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed5040150 · Cited by 139
Dengue vaccines: progress and challenges
Coller, B.-A., & Clements, D. E. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.03.005 · Cited by 115
“Cumulatively, these factors result in a complex, constantly changing, epidemiologic picture of dengue and presents unique challenges for vaccine introduction [1,4,18].”
BackgroundClimate change and dengue fever transmission in China: Evidences and challenges
Li, C., Lu, Y., Liu, J., & Wu, X. (2017) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2017.11.326 · Cited by 115
“It is considered as an endemic or epidemic disease in nearly 119 countries, many of which are in Asia (Bhatt et al., 2013; Guzman et al., 2010).”
BackgroundEconomic and Disease Burden of Dengue in Mexico
Undurraga, E. A., Betancourt-Cravioto, M., Ramos‐Castañeda, J., Martínez-Vega, R. A., Méndez-Galván, J. F., Gubler, D. J., Guzmán, M. G., Halstead, S. B., Harris, E., Kuri-Morales, P. A., et al. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003547 · Cited by 132
“Dengue fever is the most important arthropod-borne viral disease affecting humans, with about half the world’s population estimated to be at risk of infection, and epidemics increasing in frequency, magnitude, and geographical reach [1–4].”
BackgroundSelf-citationChoi, J. R., Yong, K. W., Tang, R., Gong, Y. M., Wen, T., Yang, H., Li, A., Chia, Y. C., Pingguan‐Murphy, B., & Xu, F. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600920 · Cited by 114
Balinsky, C. A., Schmeisser, H., Ganesan, S., Singh, K., Pierson, T. C., & Zoon, K. C. (2013) · Journal of Virology · doi:10.1128/jvi.00704-13 · Cited by 113
“The most severe clinical manifestations of dengue are associated with secondary infections by a heterologous DENV serotype (2).”
BackgroundLópez‐Medina, E., Biswal, S., Sáez‐Llorens, X., Borja-Tabora, C., Bravo, L. C., Sirivichayakul, C., Vargas, L. M., Alera, M. T., Velásquez, H., Reynales, H., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa761 · Cited by 113
“The 4 serotypes of dengue viruses (DENV-1 to DENV-4) are primarily transmitted to humans by the Aedes aegypti mosquito and lead to approximately 390 million dengue infections every year, 96 million of which manifest clinically [1], with 500 000 cases requiring hospitalization [2].”
Assessing the global dengue burden: Incidence, mortality, and disability trends over three decades
Zhang, W., Zhao, T., Wang, C.-C., He, Y., Lu, H., Zhang, H., Wang, L., Zhang, M., Li, C., & Deng, S. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0012932 · Cited by 112
“However, the current effectiveness of these methods remains limited [19].”
Characterizing a large outbreak of dengue fever in Guangdong Province, China
Xiao, J., He, J., Deng, A., Lin, H., Song, T., Peng, Z., Zou, X., Liu, T., Li, Z., Rutherford, S., et al. (2016) · Infectious Diseases of Poverty · doi:10.1186/s40249-016-0131-z · Cited by 115
“In addition, the poor solid waste management in some villages of the PRD is common, which may contribute to the outbreak of dengue fever [32].”
BackgroundAndries, A.-C., Duong, V., Ngan, C., Ong, S., Huy, R., Sroin, K. K., Te, V., Bunthin, Y., Try, P. L., & Buchy, P. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001993 · Cited by 109
“Serological diagnosis by ELISA or rapid diagnostic tests (RDTs) is technically easy to perform and provides fast results but requires most of the time paired sera to definitively confirm the diagnosis [1,3].”
MethodSelf-citationSantiago, G. A., Vergne, E., Quiles, Y., Cosme, J., Vázquez, J., Medina, J. F., Medina, F. A., Colón, C., Margolis, H. S., & Muñoz‐Jordán, J. L. (2013) · PLoS neglected tropical diseases · doi:10.1371/annotation/ae27d48b-025f-47ce-8427-4af59f821ad7 · Cited by 109
Self-citationHenriques, H. R., Rampazo, E. V., Gonçalves, A. J. S., Vicentin, E. C. M., Amorim, J. H., Panatieri, R. H., Amorim, K. N. D. S., Yamamoto, M. M., Ferreira, L. C. D. S., Alves, A. M. B., et al. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002330 · Cited by 107
“Dengue fever is a mosquito-borne disease caused by four distinct viral serotypes (DENV1, 2, 3 and 4) [1,2].”
BackgroundDengue infections in travellers
Wilder‐Smith, A. (2012) · Paediatrics and International Child Health · doi:10.1179/2046904712z.00000000050 · Cited by 107
Dhanoa, A., Hassan, S. S., Ngim, C. F., Lau, C. F., Chan, T. S., Adnan, N. A. A., Eng, W. W. H., Gan, H. M., & Rajasekaram, G. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1731-8 · Cited by 112
“DENV is transmitted to humans by the Aedes mosquito, principally the Aedes aegypti mosquito [5].”
BackgroundRole of Humoral versus Cellular Responses Induced by a Protective Dengue Vaccine Candidate
Zellweger, R. M., Miller, R., Eddy, W. E., White, L., Johnston, R. E., & Shresta, S. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003723 · Cited by 104
Global dengue epidemiology trends
Ferreira, G. L. C. (2012) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652012000700003 · Cited by 104
Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India
Chandele, A., Sewatanon, J., Gunisetty, S., Singla, M., Onlamoon, N., Akondy, R. S., Kissick, H. T., Nayak, K., Reddy, E. S., Kalam, H., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01424-16 · Cited by 111
Ng, J. K. W., Zhang, S. L.-X., Tan, H. C., Yan, B., Gómez, J. M. M., Tan, W. Y., Lam, J. H., Tan, G. K. X., Ooi, E. E., & Alonso, S. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004031 · Cited by 103
“Dengue (DEN) is the most prevalent arthropod-borne viral infection in the world [1].”
BackgroundNg, A. W. W., & Teoh, S. C. B. (2014) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2014.07.003 · Cited by 111
Phakhounthong, K., Chaovalit, P., Jittamala, P., Blacksell, S. D., Carter, M. J., Turner, P., Chheng, K., Sona, S., Kumar, V. S., Day, N., et al. (2018) · BMC Pediatrics · doi:10.1186/s12887-018-1078-y · Cited by 108
“More than 50 million dengue infections are estimated to occur annually, of which approximately 500,000 result in hospital admissions for severe dengue in the form of dengue haemorrhagic fever (DHF) or dengue shock syndrome (DSS), principally among children [5].”
BackgroundZerfu, B., Kassa, T., & Legesse, M. (2023) · Tropical Medicine and Health · doi:10.1186/s41182-023-00504-0 · Cited by 102
“The disease is endemic in many countries in WHO regions of Africa, the Americas, the Eastern Mediterranean, Asia, Australia and the Western Pacific [1, 25, 26], though the Americas, South–East Asia and Western Pacific regions are the most seriously affected, with Asia representing ~ 70% of the global burden of DF dise…”
BackgroundDengue is still an imported disease in China: A case study in Guangzhou
Sang, S., Chen, B., Wu, H., Yang, Z., Di, B., Wang, L., Tao, X., Liu, X., & Liu, Q. (2015) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2015.03.005 · Cited by 110
Requirement of cholesterol in the viral envelope for dengue virus infection
Carro, A. C., & Damonte, E. B. (2013) · Virus Research · doi:10.1016/j.virusres.2013.03.005 · Cited by 113
Ridde, V., Agier, I., Bonnet, E., Carabalí, M., Dabiré, R. K., Fournet, F., Ly, A., Meda, I. B., & Parra, B. (2016) · Infectious Diseases of Poverty · doi:10.1186/s40249-016-0120-2 · Cited by 106
The capacitive sensing of NS1 Flavivirus biomarker
Cecchetto, J., Fernandes, F. C. B., Lopes, R. S., & Bueno, P. R. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.08.097 · Cited by 100
Protective Role of Cross-Reactive CD8 T Cells Against Dengue Virus Infection
Ngono, A. E., Chen, H., Tang, W. W., Joo, Y., King, K., Weiskopf, D., Sidney, J., Sette, A., & Shresta, S. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.10.006 · Cited by 100
“The incidence of DENV infections in endemic areas has increased 30-fold in the past 50 years due to demographic changes, urbanization and globalization (Halstead, 2007; Guzman et al., 2010).”
BackgroundEffects of high temperatures and heatwaves on dengue fever: a systematic review and meta-analysis
Damtew, Y. T., Tong, M., Varghese, B. M., Anikeeva, O., Hansen, A. L., Dear, K. B. G., Zhang, Y., Morgan, G. G., Driscoll, T., Capon, T., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104582 · Cited by 115
Autoimmunity in dengue pathogenesis
Wan, S.-W., Lin, C., Yeh, T., Liu, C., Liu, H., Wang, S., Ling, P., Anderson, R., Lei, H.-Y., & Lin, Y.-S. (2012) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2012.11.006 · Cited by 98
“All four DENV serotypes are now circulating in these areas.(2) The transmission efficiency and disease expression between the serotypes are still uncertain, but DENV-2 and DENV-3 might contribute the most to disease severity and mortality.”
Backgroundvan Cleef, K. W. R., Overheul, G. J., Thomassen, M. C., Kaptein, S. J. F., Davidson, A. D., Jacobs, M., Neyts, J. H., van Kuppeveld, F. J. M., & van Rij, R. P. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.05.011 · Cited by 104
“The incidence of DENV infections has increased dramatically during the last decades and the virus is now endemic in more than 100 countries (Guzman and Istúriz, 2010; Guzman et al., 2010; WHO, 2013).”
Tsai, W.-Y., Lai, C.-Y., Wu, Y.-C., Lin, H.-E., Edwards, C., Jumnainsong, A., Kliks, S. C., Halstead, S. B., Mongkolsapaya, J., Screaton, G. R., et al. (2013) · Journal of Virology · doi:10.1128/jvi.00871-13 · Cited by 97
“million DENV infections occur every year worldwide (1, 2).”
BackgroundSelf-citationAyyappan, S., Murugan, K., Kovendan, K., Kumar, P. M., & Hwang, J. (2013) · Parasitology Research · doi:10.1007/s00436-012-3269-z · Cited by 101
“It is endemic to tropical and subtropical countries, especially in the urban and suburban areas (Guzman et al. 2010).”
BackgroundDengue Virus Glycosylation: What Do We Know?
Yap, S. S. L., Nguyen‐Khuong, T., Rudd, P. M., & Alonso, S. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01415 · Cited by 104
“Four serotypes of DENV (DENV1-4) have been identified to date and co-circulation of these serotypes has been reported in Asia, Africa, and America (Guzman et al., 2010).”
BackgroundSharma, N., Mishra, K. P., Chanda, S., Bhardwaj, V., Tanwar, H., Ganju, L., Kumar, B., & Singh, S. B. (2019) · Archives of Virology · doi:10.1007/s00705-019-04179-z · Cited by 96
Replication in Cells of Hematopoietic Origin Is Necessary for Dengue Virus Dissemination
Pham, A. M., Langlois, R. A., & tenOever, B. R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002465 · Cited by 103
“Consequently, a heterotypic secondary infection with a different serotype can lead to more severe or fatal clinical manifestations such as DHF/DSS [7].”
BackgroundInfluentialChanging epidemiology of dengue in South-East Asia
Sunyoto, T., Bhatia, R., & Dash, A. (2013) · WHO South-East Asia Journal of Public Health · doi:10.4103/2224-3151.115830 · Cited by 96
“[7]”
Leo, Y., Wilder‐Smith, A., Archuleta, S., Shek, L. P., Chong, C. Y., Leong, H. N., Low, C. Y., Oh, M. L. H., Bouckenooghe, A. R., Wartel, T. A., et al. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.21224 · Cited by 95
“%) participants in the countries,8 many of whom live in urban areas of tropical and sub-tropical countries in the Americas, Southeast Asia, and the Western Pacific.9 The latter two regions account for 75% of the global burden of dengue disease.10 In addition, disease incidence varies by age.”
BackgroundCurious entanglements: interactions between mosquitoes, their microbiota, and arboviruses
Caragata, E. P., Tikhe, C. V., & Dimopoulos, G. (2019) · Current Opinion in Virology · doi:10.1016/j.coviro.2019.05.005 · Cited by 95
“Mosquito-transmitted viral diseases, including dengue (DENV), chikungunya (CHIKV), Japanese encephalitis (JEV), West Nile (WNV), yellow fever (YFV), and Zika (ZIKV), are a serious public health problem, causing millions of infections per year [1-3].”
BackgroundNicolelis, M. A. L., Raimundo, R. L. G., Peixoto, P. S., & de Andreazzi, C. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-92263-3 · Cited by 120
Bull, J. J., & Turelli, M. (2013) · Evolution Medicine and Public Health · doi:10.1093/emph/eot018 · Cited by 110
“Dengue is a viral disease of humans, now endemic on three continents, affecting approximately one-third of the human population [17, 18].”
BackgroundHamrick, P. N., Aldighieri, S., Machado, G., Galan, D. I., Vilca, L. M., Uriona, S., & Schneider, M. C. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005897 · Cited by 101
Dengue in Araraquara, state of São Paulo: epidemiology, climate and Aedes aegypti infestation
Ferreira, A. C., Neto, F. C., & Mondini, A. (2018) · Revista de Saúde Pública · doi:10.11606/s1518-8787.2018052000414 · Cited by 94
Estimating the Risk of Vertical Transmission of Dengue: A Prospective Study
Basurko, C., Matheus, S., Hilderal, H., Everhard, S., Restrepo, M., Cuadro-Alvarez, E., Lambert, V., Boukhari, R., Duvernois, J.-P., Favre, A., et al. (2018) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0794 · Cited by 94
Exploitation of cellular pathways by Dengue virus
Fischl, W., & Bartenschlager, R. F. W. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.07.012 · Cited by 105
Alonzo, M. T. G., Lacuesta, T. L., Dimaano, E. M., Kurosu, T., Suarez, L.-A. C., Mapua, C. A., Akeda, Y., Matias, R. R., Kuter, D. J., Nagata, S., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis180 · Cited by 93
“Pretreatment with a caspase 3 inhibitor reduced significantly the phagocytosis of platelets pretreated with CTR cultured in medium only (P , .01) or in medium containing DV4 (P , .0001).”
BackgroundInfluentialHigh-Throughput Screening Using Dengue Virus Reporter Genomes
Fischl, W., & Bartenschlager, R. F. W. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-484-5_17 · Cited by 93
The Mosquito Larvicidal Activity of Essential Oils from Cymbopogon and Eucalyptus Species in Vietnam
Manh, H. D., Hue, D. T., Hieu, N. T. T., Tuyen, D. T. T., & Tuyet, O. T. (2020) · Insects · doi:10.3390/insects11020128 · Cited by 97
“[1,2] The Aedes mosquito is the primary vector for the transmission of dengue fever.”
BackgroundSerotype-specific Differences in Dengue Virus Non-structural Protein 5 Nuclear Localization
Hannemann, H., Sung, P.-Y., Chiu, H.-C., Yousuf, A., Bird, J., Lim, S. P., & Davidson, A. D. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.481382 · Cited by 105
“It is estimated that 50–100million cases of dengue fever and 250,000 cases of dengue hemorrhagic fever occur annually (1, 2).”
BackgroundGenomic analysis and growth characteristic of dengue viruses from Makassar, Indonesia
Sasmono, R. T., Wahid, I., Trimarsanto, H., Yohan, B., Wahyuni, S., Hertanto, M., Yusuf, I., Mubin, H., Ganda, I. J., Latief, R., et al. (2015) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2015.03.006 · Cited by 91
From dengue to Zika: the wide spread of mosquito-borne arboviruses
Sukhralia, S., Verma, M., Gopirajan, S., Dhanaraj, P. S., Lal, R., Mehla, N., & Kant, C. R. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3375-7 · Cited by 100
“Major parts of the world that are affected by it are Southeast Asia, the Pacific and the Americas, whereas Africa and the East Mediterranean are getting increasingly affected [15] (Fig.”
BackgroundInfluentialAraújo, A. P. A., Diniz, D. F. A., Helvécio, E., de Barros, R. A., de Oliveira, C. M. F., Ayres, C. F. J., de Melo-Santos, M. A. V., Regis, L., & Silva‐Filha, M. H. N. L. (2013) · Parasites & Vectors · doi:10.1186/1756-3305-6-297 · Cited by 97
“Background Aedes aegypti is the major vector of dengue virus (DENv) and has been responsible for an important disease burden in human populations worldwide in the last few decades [1,2].”
BackgroundModified mRNA-LNP Vaccines Confer Protection against Experimental DENV-2 Infection in Mice
Zhang, M., Sun, J., Li, M., & Jin, X. (2020) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2020.07.013 · Cited by 90
“The current effort for the development of vaccine against DENV is thought to be hampered by antibody-dependent enhancement (ADE), a phenomenon that seems to exacerbate some DENV infections.(4) Although primary infection with one DENV serotype can elicit lifelong protective immunity, a secondary infection by a differen…”
BackgroundFredeking, T., Zavala-Castro, J. E., Gonzalez-Martinez, P., Moguel-Rodríguez, W., Sanchez, E., Foster, M., & Díaz-Quijano, F. A. (2015) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/1574891x10666150410153839 · Cited by 90
“5-20% of patients [6].”
BackgroundInfluentialLuna, D. M. N., Avelino, K. Y. P. S., Cordeiro, M. T., Andrade, C. A. S., & Oliveira, M. D. L. (2015) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2015.05.067 · Cited by 90
Dengue: an escalating public health problem in Latin America
TAPIA-CONYER, R. C., Betancourt-Cravioto, M., & Méndez-Galván, J. F. (2012) · Paediatrics and International Child Health · doi:10.1179/2046904712z.00000000046 · Cited by 90
Sirivichayakul, C., Barranco-Santana, E. A., Esquilin, I. O., Oh, H. M. L., Raanan, M. G., Sariol, C. A., Shek, L. P., Simasathien, S., Smith, M. K., Vélez, I. D., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv762 · Cited by 90
Baquero, O. S., Santana, L. M. R., & Neto, F. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195065 · Cited by 94
MicroRNA-30e* Suppresses Dengue Virus Replication by Promoting NF-κB–Dependent IFN Production
Zhu, X., He, Z., Hu, Y., Wen, W., Lin, C., Yu, J., Pan, J., Li, R., Deng, H., Liao, S., et al. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003088 · Cited by 98
“An estimated more than 50 million people contract dengue virus annually, leading to approximately 500,000 hospitalizations and 25,000 deaths, particularly among children [3].”
BackgroundVerhagen, L. M., & de Groot, R. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.07.020 · Cited by 115
“Although children usually suffer from high fever, they are generally less symptomatic than adults during this phase of the illness.(20) Mild hemorrhagic manifestations like petechiae and mucosal membrane bleeding (e.”
BackgroundInfluentialOsorio, J. E., Wallace, D., & Stinchcomb, D. T. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1128328 · Cited by 88
“● PrM and E are needed to induce the neutralizing antibodies to DENV-1–4; the nonstructural (NS) proteins expressed from the dengue backbone are required to generate T cell-mediated responses to dengue infection, and antibodies against NS1 are associated with cross-protective humoral immune responses.”
BackgroundInfluentialAssessing the interplay between human mobility and mosquito borne diseases in urban environments
Massaro, E., Kondor, D., & Ratti, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-53127-z · Cited by 88
“e: tSV!EV t;c =BD(S V t;c;l h!v t;c =2) (16) tEV!IV t;c =BD(E V t;c;g˙ v=2) (17) SV t+1;c =S V t;c t SV!EV t;c (18) EV t+1;c =E V t;c +t SV!EV t;c t EV!IV t;c (19) IV t+1;c =I V t;c +t EV!IV t;c (20) (21) where the transition rate human-to-vector lh!v t;c is defined as 14: lh!v t;c =af˙ h!vSV t;c Iv t;c N t;c : (22) Th…”
Clinical implications and treatment of dengue
Chawla, P. A., Yadav, A., & Chawla, V. (2014) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(14)60016-x · Cited by 108
“aegypti has a generally low susceptibility to oral infection with dengue virus, it remains the most important vector because of its highly domesticated habits[16].”
BackgroundSmith, S. A., de Alwis, R., Kose, N., Durbin, A. P., Whitehead, S. S., de Silva, A. M., & Crowe, J. E. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit119 · Cited by 87
The next decade of vaccines: societal and scientific challenges
Moxon, E. R., & Siegrist, C. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60407-8 · Cited by 94
CD8 + T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice
Zellweger, R. M., Tang, W. W., Eddy, W. E., King, K., Sanchez, M., & Shresta, S. (2015) · Journal of Virology · doi:10.1128/jvi.00036-15 · Cited by 86
The dengue virus non-structural 1 protein: Risks and benefits
Amorim, J. H., Alves, R. P. D. S., Boscardin, S. B., & Ferreira, L. C. D. S. (2014) · Virus Research · doi:10.1016/j.virusres.2014.01.001 · Cited by 86
Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice
Fowler, A. M., Tang, W. W., Young, M. P., Mamidi, A., Viramontes, K. M., McCauley, M., Carlin, A. F., Schooley, R. T., Swanstrom, J., Baric, R. S., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.09.015 · Cited by 89
“DENV is the leading mosquito-transmitted viral infection globally (Guzman et al., 2010) with an estimated 390 million infections per year, and results in clinical symptoms ranging from inapparent to life-threatening (Bhatt et al.”
BackgroundZüst, R., Toh, Y. T., Valdés, I., Cerny, D., Heinrich, J., Hermida, L., López, E. M., Guillén, G. E., Kalinke, U., Shi, P., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03827-13 · Cited by 96
Conformational changes in intact dengue virus reveal serotype-specific expansion
Lim, X.-X., Chandramohan, A., Lim, X. Y., Bag, N., Sharma, K. K., Wirawan, M., Wohland, T., Lok, S., & Anand, G. S. (2017) · Nature Communications · doi:10.1038/ncomms14339 · Cited by 85
Roth, C., Cantaert, T., Colas, C., Prot, M., Casadémont, I., Levillayer, L., Thalmensi, J., Langlade-Demoyen, P., Gerke, C., Bahl, K., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01424 · Cited by 84
Amorim, J. H., Diniz, M. O., Cariri, F. A. M. O., Rodrigues, J. F., Bizerra, R. S. P., Gonçalves, A. J. S., Alves, A. M. B., & Ferreira, L. C. D. S. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.12.034 · Cited by 84
“[1] Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, et al.”
BackgroundDengue fever: a Wikipedia clinical review.
Heilman, J., de Wolff, J., Beards, G. M., & Basden, B. J. (2014) · Europe PMC (PubMed Central) · Cited by 84
Prayitno, A., Taurel, A.-F., Nealon, J., Satari, H. I., Karyanti, M. R., Sekartini, R., Soedjatmiko, S., Gunardi, H., Medise, B. E., Sasmono, R. T., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005621 · Cited by 99
Increasing Dengue Burden and Severe Dengue Risk in Bangladesh: An Overview
Kayesh, M. E. H., Khalil, I., Kohara, M., & Tsukiyama–Kohara, K. (2023) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed8010032 · Cited by 110
“The DENV genome encodes three structural proteins, namely the capsid (C), membrane (M), and envelope (E) proteins, and seven nonstructural proteins, including NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5 [19,21].”
BackgroundInfluentialChang, F.-S., Tseng, Y.-T., Hsu, P.-S., Chen, C.-D., Lian, I., & Chao, D. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004043 · Cited by 83
“This mosquito-borne disease is caused by four serotypes of dengue virus (DENV-1 to 4), which belong to the family Flaviviridae, genus Flavivirus[2].”
BackgroundPaul, A. M., Fan, Z., Sinha, S. S., Shi, Y., Le, L., Bai, F., & Ray, P. C. (2015) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.5b07387 · Cited by 85
Fagundes, C. T., Costa, V. V., Cisalpino, D., Amaral, F. A., Souza, P. R., de Souza, R. S. C., Ryffel, B., Vieira, L. Q., Silva, T. A., Atrasheuskaya, A. V., et al. (2011) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001449 · Cited by 95
“Risk factors for severe disease include age [1,4], viral serotype [1,5] and genotype [1,6,7], and the genetic background of the host [1,8], among others.”
BackgroundXiao, J., Liu, T., Lin, H., Zhu, G., Zeng, W., Li, X., Zhang, B., Song, T., Deng, A., Zhang, M., et al. (2017) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2017.12.200 · Cited by 83
“With climate change, globalization and urbanization, dengue could become a more serious public health threat in the future in Guangdong (Guzman et al., 2010; Qin and Shi, 2014; Sun et al., 2016; Xiao et al., 2016).”
BackgroundAn emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection
Tsai, T., Chuang, Y.-J., Lin, Y.-S., Wan, S.-W., Chen, C., & Lin, C. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-40 · Cited by 93
“The newly synthesized viral RNA is incorporated into viral proteins and assembled into immature virions within the ER lumen [3-5].”
BackgroundHernández, S. I. D. L. C., Flores-Aguilar, H., González-Mateos, S., López-Martı́nez, I., Alpuche-Aranda, C. M., Ludert, J. E., & del Angel, R. M. (2013) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.12-0023 · Cited by 82
“Each year, more than 50 million cases occur, which are associated with more than 25,000 deaths, especially in children less than five years of age.(1) Dengue is endemic to more than 100 countries and nearly one-third on the world’s population lives in risk areas, which are tropical and subtropical regions.”
BackgroundChuaycharoensuk, T., Juntarajumnong, W., Boonyuan, W., Bangs, M. J., Akratanakul, P., Thammapalo, S., Jirakanjanakit, N., Tanasinchayakul, S., & Chareonviriyaphap, T. (2011) · Journal of Vector Ecology · doi:10.1111/j.1948-7134.2011.00158.x · Cited by 81
“Dengue is the most common vector-borne viral disease globally, primarily affecting developing countries of tropical and subtropical regions, with an estimated 2.5 to 3 billion people at risk of infection and resulting in approximately 50 million dengue infections annually (Guzman et al. 2010).”
BackgroundInfluentialDiagnosing Dengue at the Point-of-Care: Utility of a Rapid Combined Diagnostic Kit in Singapore
Gan, V. C. H., Tan, L.-K., Lye, D. C., Pok, K.-Y., Mok, S.-Q., Chua, R., Leo, Y., & Ng, L. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090037 · Cited by 83
“Classification of final dengue status was according to the following WHO-based composite standard [19,20].”
MethodInfluentialBeck, C., Desprès, P., Paulous, S., Vanhomwegen, J., Lowenski, S., Nowotny, N. R., Durand, B., Garnier, A., Blaise‐Boisseau, S., Guitton, É., et al. (2015) · BioMed Research International · doi:10.1155/2015/678084 · Cited by 82
“Research Article”
Predicting Dengue Fever Outbreaks in French Guiana Using Climate Indicators
Adde, A., Roucou, P., Mangeas, M., Ardillon, V., Desenclos, J., Rousset, D., Girod, R., Briolant, S., Quénel, P., & Flamand, C. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004681 · Cited by 84
The State of the Art of Lethal Oviposition Trap-Based Mass Interventions for Arboviral Control
Johnson, B., Ritchie, S. A., & Fonseca, D. M. (2017) · Insects · doi:10.3390/insects8010005 · Cited by 96
Metadata
- Authors
- Guzman, M. G., Halstead, S. B., Artsob, H., Buchy, P., Farrar, J., Gubler, D. J., Hunsperger, E., Kroeger, A., Margolis, H. S., Martínez, E., Nathan, M. B., Pelegrino, J. L., Simmons, C., Yoksan, S., & Peeling, R. W.
- Affiliations
- Public Health Agency of Canada (CA)
- Institut Pasteur du Cambodge (KH)
- Oxford University Clinical Research Unit (VN)
- National University of Singapore (SG)
- Centers for Disease Control and Prevention (US)
- World Bank (US)
- Instituto de Medicina Tropical “Pedro Kourí” (CU)
- World Health Organization (CH)
- Mahidol University (TH)
- Corresponding author
- Peeling, Rosanna W.
- ORCID
- Venue
- Nature Reviews Microbiology
- Published
- 2010-12
- Volume
- 8
- Issue
- S12
- Pages
- S7-S16
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- PMC
- PMC4333201
- OpenAlex
- W2042479028
- Cited by
- 2,082
- References
- 130
- Citations by year
- 2026: 68 · 2025: 104 · 2024: 94 · 2023: 135 · 2022: 116 · 2021: 133 · 2020: 140 · 2019: 127 · 2018: 142 · 2017: 151 · 2016: 163 · 2015: 189 · 2014: 186 · 2013: 161 · 2012: 132
- FWCI
- 15.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- Wellcome Trust (084368)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mosquito-borne diseases and control
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Dengue and Mosquito Control Research
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Vectors
- Keywords
- dengue, dengue hemorrhagic fever, arboviruses, dengue serotypes, vector-borne diseases, dengue surveillance, outbreak response, integrated vector management, early diagnosis, dengue vaccine, antiviral agents, dengue control
- MeSH terms
- Americas, Asia, Southeastern, Dengue, Dengue Virus, Hospitalization, Humans, Insect Control, Pacific Islands
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.